![Debjani Singh](/sites/default/files/styles/featured_square_large/public/2024-08/2024-P12408.jpg?h=8f9cfe54&itok=bP5F6U4Y)
Filter News
Area of Research
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (18)
- Clean Energy (16)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (24)
- Fusion Energy (15)
- Isotopes (5)
- Materials (27)
- Materials for Computing (2)
- National Security (3)
- Neutron Science (12)
- Nuclear Science and Technology (10)
- Supercomputing (21)
News Topics
- (-) Biomedical (60)
- (-) Critical Materials (29)
- (-) Fusion (58)
- 3-D Printing/Advanced Manufacturing (126)
- Advanced Reactors (34)
- Artificial Intelligence (99)
- Big Data (60)
- Bioenergy (92)
- Biology (100)
- Biotechnology (23)
- Buildings (63)
- Chemical Sciences (71)
- Clean Water (31)
- Climate Change (104)
- Composites (29)
- Computer Science (195)
- Coronavirus (46)
- Cybersecurity (35)
- Decarbonization (83)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (112)
- Environment (198)
- Exascale Computing (41)
- Fossil Energy (6)
- Frontier (45)
- Grid (66)
- High-Performance Computing (91)
- Hydropower (11)
- Irradiation (3)
- Isotopes (56)
- ITER (7)
- Machine Learning (50)
- Materials (146)
- Materials Science (145)
- Mathematics (9)
- Mercury (12)
- Microelectronics (4)
- Microscopy (51)
- Molten Salt (9)
- Nanotechnology (60)
- National Security (71)
- Net Zero (14)
- Neutron Science (134)
- Nuclear Energy (111)
- Partnerships (50)
- Physics (64)
- Polymers (33)
- Quantum Computing (37)
- Quantum Science (71)
- Renewable Energy (2)
- Security (25)
- Simulation (50)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (59)
- Sustainable Energy (130)
- Transformational Challenge Reactor (7)
- Transportation (97)
Media Contacts
![Kathy McCarthy, associate laboratory director for Fusion and Fission Energy and Science, has been elected fellow of the American Nuclear Society. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/2021-P00782_0.jpg?h=8f9cfe54&itok=ndt_x8A1)
Kathy McCarthy, associate laboratory director for Fusion and Fission Energy and Science at the Department of Energy’s Oak Ridge National Laboratory, has been elected fellow of the American Nuclear Society for her nationally and internationally recognized leadership in nuclear energy and fusion.
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![ORNL’s green solvent enables environmentally friendly recycling of valuable Li-ion battery materials. Credit: Andy Sproles/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/metal_03.jpg?h=5510f2c5&itok=X9YPqOe5)
Scientists at Oak Ridge National Laboratory have developed a solvent that results in a more environmentally friendly process to recover valuable materials from used lithium-ion batteries, supports a stable domestic supply chain for new batteries
![The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.](/sites/default/files/styles/list_page_thumbnail/public/2021-05/DOE%20ECRP%20winners_1.jpg?h=d1cb525d&itok=qW3-KeMF)
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![The proposed Battery Identity Global Passport suggests a scannable QR code or other digital tag affixed to Li-ion batteries to identify materials for efficient end-of-life recycling. Credit: Andy Sproles, ORNL/U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/batteryRecycle3_0.png?h=53ec4ef3&itok=3cQV5K4R)
Scientists at Oak Ridge National Laboratory have devised a method to identify the unique chemical makeup of every lithium-ion battery around the world, information that could accelerate recycling, recover critical materials and resolve a growing waste stream.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/2021-03/gif_high_res.gif)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.